Wednesday, July 10, 2019
Horizon Therapeutics announces proposed private offering of senior notes
Horizon Therapeutics (HZNP) intends to offer $500M aggregate principal amount of senior notes due 2027.
Horizon expects to use the net proceeds, together with ~$64M in cash on hand, to redeem $525M of its outstanding debt as well as to pay the related premiums, and fees and expenses, excluding accrued interest, associated with the redemption.
Subscribe to:
Posts (Atom)